China Pharma submits plan of compliance to NYSE American
The company was directed to submit a plan of compliance by July 15, 2022
The company was directed to submit a plan of compliance by July 15, 2022
The FDA's Orphan Drug Designation is granted to investigational therapies addressing rare medical diseases or conditions that affect fewer than 200,000 people
PM congratulates citizens on crossing the 200 crore milestone of Covid vaccination drive
Groundbreaking collaborative research program will explore common characteristics of glaucoma, alzheimer's
Tobacco smoke increases infant morbidity and is fatal to a baby because it damages the baby’s organs
George Svokos joins Avet after serving as a strategic business advisor to numerous global healthcare companies
To strengthen the integrated human-centric preventive health screening ‘Phygital’ ecosystem in India
ICRA expects the OPM of the sample set to moderate to 20.2% in FY2023 from 21.5% in FY2022.
Orion to receive an upfront payment of USD 290 million
Mittal will be driving expansion of the provider network across India
Subscribe To Our Newsletter & Stay Updated